摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-bis(3-cyanophenoxy)pyridine-3-carboxylic acid, ethyl ester | 183306-74-3

中文名称
——
中文别名
——
英文名称
2,6-bis(3-cyanophenoxy)pyridine-3-carboxylic acid, ethyl ester
英文别名
Ethyl 2,6-bis(3-cyanophenoxy)pyridine-3-carboxylate
2,6-bis(3-cyanophenoxy)pyridine-3-carboxylic acid, ethyl ester化学式
CAS
183306-74-3
化学式
C22H15N3O4
mdl
——
分子量
385.379
InChiKey
APORXUURFBHFMK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    29
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    105
  • 氢给体数:
    0
  • 氢受体数:
    7

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Design, Synthesis, and Activity of 2,6-Diphenoxypyridine-Derived Factor Xa Inhibitors
    摘要:
    A novel series of 2,6-diphenoxypyridines has been designed to inhibit factor Xa, a serine protease strategically located in the coagulation cascade. The evolution from the photochemically unstable bisamidine (Z,Z)-BABCH to potent bisamidine compounds with a pyridine heterocycle as the core scaffold has been achieved. The most potent compound in the series, 6h, has a K-i for human factor Xa of 12 nM. The selectivity of 6h against bovine trypsin and human thrombin was greater than 90- and 1000-fold, respectively. Two proposed modes of binding of 6h Do factor Xa are made based on the crystal structures of 6h by itself and of 6h bound to bovine trypsin.
    DOI:
    10.1021/jm980667k
  • 作为产物:
    参考文献:
    名称:
    Benzamidine derivatives and their use as anti-coagulants
    摘要:
    这项发明涉及对苯甲酰胺衍生物的研究,这些衍生物可用作抗凝剂。该发明还涉及含有该发明中化合物的药物组合物,以及使用这些化合物治疗由血栓活动特征的疾病状态的方法。
    公开号:
    US06350746B1
点击查看最新优质反应信息

文献信息

  • Benzamidine derivatives and their use as anti-coagulants
    申请人:Berlex Laboratories, Inc.
    公开号:US06350746B1
    公开(公告)日:2002-02-26
    This invention is directed to benzamidine derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
    这项发明涉及对苯甲酰胺衍生物的研究,这些衍生物可用作抗凝剂。该发明还涉及含有该发明中化合物的药物组合物,以及使用这些化合物治疗由血栓活动特征的疾病状态的方法。
  • Design, Synthesis, and Activity of 2,6-Diphenoxypyridine-Derived Factor Xa Inhibitors
    作者:Gary Phillips、David D. Davey、Keith A. Eagen、Sunil K. Koovakkat、Amy Liang、Howard P. Ng、Michael Pinkerton、Lan Trinh、Marc Whitlow、Alicia M. Beatty、Michael M. Morrissey
    DOI:10.1021/jm980667k
    日期:1999.5.1
    A novel series of 2,6-diphenoxypyridines has been designed to inhibit factor Xa, a serine protease strategically located in the coagulation cascade. The evolution from the photochemically unstable bisamidine (Z,Z)-BABCH to potent bisamidine compounds with a pyridine heterocycle as the core scaffold has been achieved. The most potent compound in the series, 6h, has a K-i for human factor Xa of 12 nM. The selectivity of 6h against bovine trypsin and human thrombin was greater than 90- and 1000-fold, respectively. Two proposed modes of binding of 6h Do factor Xa are made based on the crystal structures of 6h by itself and of 6h bound to bovine trypsin.
查看更多